STOK: Allan Jonathan discloses a sale

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

Allan Jonathan

Reporting filer

Allan Jonathan reported Sale in Stoke Therapeutics, Inc.: 627 units of Common Stock, dated 2026-10-02. The full Form 4 contains 1 transaction entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Allan Jonathan	2026-10-02	S	Sale	627	26.33	20,598	0 days	Filed terms security Title: Common Stock transaction Date: 2026-10-02 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F1 transaction Shares: 627 transaction Price Per Share: 26.33 transaction Acquired Disposed Code: D shares Owned Following Transaction: 20598 direct Or Indirect Ownership: D nature Of Ownership:

Owner: Allan Jonathan
Date: 2026-10-02
Code: S
Action: Sale
Quantity: 627
Price: 26.33
Following holdings: 20,598
Reporting delay: 0 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-02
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 627
transaction Price Per Share: 26.33
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 20598
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Allan Jonathan: GENERAL COUNSEL & CORP SEC.
The filing reports a Rule 10b5-1 trading plan.
F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.

Prepared automatically from public filing data. Report a correction.